GT Biopharma reports FY results
Source: SeekingAlpha
2026-03-02 14:42:40 ET
More on GT Biopharma
- Seeking Alpha’s Quant Rating on GT Biopharma
- Historical earnings data for GT Biopharma
- Financial information for GT Biopharma
Read the full article on Seeking Alpha
For further details see:
GT Biopharma reports FY results
GT Biopharma Inc.
NASDAQ: GTBP
GTBP Trading
37.97% G/L:
$0.44 Last:
8,878,967 Volume:
$0.374 Open:
GTBP Latest News
May 14, 2026 12:45:00 pm
First Patient Dosed in Phase 1 Trial Marks Expansion of NK Cell Engager Platform Into Solid Tumors
May 14, 2026 10:55:00 am
"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
May 14, 2026 09:15:00 am
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
GTBP Stock Data
$13,901,784
16,849,517
7.73%
17
N/A
Biotechnology & Life Sciences
Healthcare
US
San Francisco
